Prevalence of antibodies to HTLV-I,-II, and-III in intravenous drug abusers from an AIDS endemic region

M Robert-Guroff, SH Weiss, JA Giron, AM Jennings… - Jama, 1986 - jamanetwork.com
Antibody prevalences for human T-cell lymphotropic virus (HTLV) types I, II, and III were
determined for 56 intravenous drug abusers from Queens, NY. While control serum samples …
被引用次数：431 相关文章

[引用][C] Prevalence of antibodies to HTLV-I,-II, and-III in intravenous drug abusers from an AIDS endemic region

M ROBERT-GUROFF - JAMA, 1986 - cir.nii.ac.jp
Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS
endemic region | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Prevalence of antibodies to HTLV-I,-II, and-III in intravenous drug abusers from an AIDS endemic region.

M Robert-Guroff, SH Weiss, JA Giron, AM Jennings… - JAMA, 1986 - europepmc.org
Antibody prevalences for human T-cell lymphotropic virus (HTLV) types I, II, and III were
determined for 56 intravenous drug abusers from Queens, NY. While control serum samples …

Prevalence of antibodies to HTLV-I,-II, and-III in intravenous drug abusers from an AIDS endemic region.

M Robert-Guroff, SH Weiss, JA Giron - 1986 - cabidigitallibrary.org
Antibody prevalences for human T-cell lymphotropic virus (HTLV) types I, II, and III were
determined for 56 intravenous drug abusers from Queens, NY. While control serum samples …

Prevalence of antibodies to HTLV-I,-II, and-III in intravenous drug abusers from an AIDS endemic region

M Robert-Guroff, SH Weiss, JA Giron… - …, 1986 - pubmed.ncbi.nlm.nih.gov
Antibody prevalences for human T-cell lymphotropic virus (HTLV) types I, II, and III were
determined for 56 intravenous drug abusers from Queens, NY. While control serum samples …

Prevalence of Antibodies to HTLV-I,-II, and-III in Intravenous Drug Abusers From an AIDS Endemic Region

M Robert-Guroff, SH Weiss, JA Giron… - JAMA: The Journal …, 1986 - researchwithrutgers.com
Antibody prevalences for human T-cell lymphotropic virus (HTLV) types I, II, and III were
determined for 56 intravenous drug abusers from Queens, NY. While control serum samples …